
---
nice.evidencecategory: 
---

### Evidence Statement CG66ES209
CAPRIE: Post hoc sub-analysisThis sub-analysis found a significantly lower incidence of CV events in diabetic patients receiving clopidogrel compared to those treated with aspirin. Furthermore, the incidence of rehospitalisation for any bleeding event was significantly lower with clopidogrel than with the aspirin group (see table 15.1). Level 1+

[@Bhatt_2002]

